<DOC>
	<DOCNO>NCT00575159</DOCNO>
	<brief_summary>The purpose research study look concentration GSK189075 blood single dos drug take mouth combination basal insulin . The clinical effect drug combination insulin body also study . The result help determine dos GSK189075 study future type I diabetes mellitus population .</brief_summary>
	<brief_title>A Study Assess Safety Single Doses GSK189075 Subjects With Type 1 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Adult male/female , 18 55 year old Diagnosis type 1 diabetes mellitus least 6 month ; use continuous insulin pump Willing able follow studyrelated instruction provide site staff . Willing provide sign informed consent . Pregnant nursing female . Have past current disease heart , liver , kidney , blood , brain , disease . Have HIV hepatitis , alcohol drug system screen visit . Have history alcohol abuse eat disorder Have another research study last month take certain medication 1 week study drug would take .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Adult male female ,</keyword>
	<keyword>type 1 Diabetes mellitus , pharmacokinetics ,</keyword>
	<keyword>pharmacodynamics</keyword>
</DOC>